Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 18 OTHER 12 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Mantle-Cell 1

Interventions

Radiotherapy 41 Cisplatin 36 Fluorouracil 17 Paclitaxel 15 Docetaxel 14 Cyclophosphamide 14 Carboplatin 14 Filgrastim 13 Doxorubicin 13 Gemcitabine 11 Etoposide 11 Capecitabine 10 Surgical Procedures, Operative 9 Methotrexate 9 Leucovorin 9 Chemotherapy, Adjuvant 9 Vincristine 8 Peripheral Blood Stem Cell Transplantation 8 Oxaliplatin 8 Dexamethasone 7 Bevacizumab 7 Topotecan 6 Radiotherapy, Conformal 6 Prednisone 6 Fenretinide 6 Cetuximab 6 Neoadjuvant Therapy 5 Mitomycin 5 Irinotecan 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × obinutuzumab × Clear all

NCT03229382 2023-08-16

OPERA-PLRG10

Polish Lymphoma Research Group

Phase 2 Terminated

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡